, Morgenstern O: Theory of Games and Economic Behavior, 1944.
Utility approach to measuring health-related quality of life, J Chronic Dis, vol.40, pp.593-603, 1987. ,
Advantages and limitations of utility assessment methods in rheumatoid arthritis, J Rheumatol, vol.34, pp.2193-2200, 2007. ,
Health related utility measurement: an introduction, J Rheumatol, vol.22, pp.1197-1199, 1995. ,
A utility maximization model for evaluation of health care programs, Health Serv Res, vol.7, pp.118-133, 1972. ,
The standard gamble showed better construct validity than the time trade-off, J Clin Epidemiol, vol.60, pp.1029-1033, 2007. ,
A new explanation for the difference between time trade-off utilities and, Health Econ, vol.11, pp.447-456, 2002. ,
Variability among methods to assess patients' well-being and consequent effect on a cost-effectiveness analysis, J Clin Epidemiol, vol.45, pp.505-512, 1992. ,
Valuing health states: a comparison of methods, J Health Econ, vol.15, pp.209-231, 1996. ,
An investigation into the empirical validity of the EQ-5D and SF-6D based on hypothetical preferences in a general population, Health Econ, vol.14, pp.1169-1189, 2005. ,
Multi-attribute health status classification systems, Health Utilities Index. Pharmacoeconomics, vol.7, pp.490-502, 1995. ,
Utility approach to measuring health-related quality of life, Journal of Chronic Diseases, vol.40, issue.6, pp.593-603, 1987. ,
Advantages and limitations of utility assessment methods in rheumatoid arthritis, Journal of Rheumatology, vol.34, issue.11, pp.2193-200, 2007. ,
The standard gamble method: what is being measured and how it is interpreted, Health Services Research, vol.29, issue.2, pp.207-231, 1994. ,
A utility maximization model for evaluation of health care programs, Health Services Research, vol.7, issue.2, pp.118-151, 1972. ,
Health related utility measurement: an introduction, Journal of Rheumatology, vol.22, issue.6, pp.1197-1206, 1995. ,
An investigation into the empirical validity of the EQ-5D and SF-6D based on hypothetical preferences in a general population, Health Economics, vol.14, issue.11, pp.1169-89, 2005. ,
Multi-attribute health status classification systems. Health utilities index, Pharmacoeconomics, vol.7, issue.6, pp.490-502, 1995. ,
, EuroQol -a new facility for the measurement of health-related quality of life. The EuroQol group, Health Policy, vol.16, issue.3, pp.199-208, 1990.
The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection, Medical Care, vol.30, issue.6, pp.473-83, 1992. ,
Discrete choice experiments in health economics. For better or for worse? The European Journal of Health Economics, vol.5, pp.199-202, 2004. ,
The pre-therapeutic classification of co-morbidity in chronic disease, Journal of Chronic Diseases, vol.23, issue.7, pp.455-68, 1970. ,
Multimorbidity and quality of life in primary care: a systematic review, Health and Quality of Life Outcomes, vol.2, p.51, 2004. ,
The treatment of unrelated disorders in patients with chronic medical diseases, The New England Journal of Medicine, vol.338, issue.21, pp.1516-1536, 1998. ,
Cartilage in normal and osteoarthritis conditions, Best Practice & Research Clinical Rheumatology, vol.22, issue.2, pp.351-84, 2008. ,
The economic burden of osteoarthritis, American Journal of Managed Care, vol.15, issue.8, pp.230-235, 2009. ,
Health care costs in US patients with and without a diagnosis of osteoarthritis, Journal of Pain Research, vol.2012, issue.5, pp.23-30, 2012. ,
Comorbid conditions in the AMICA study patients: effects on the quality of life and drug prescriptions by general practitioners and specialists, Seminars in Arthritis and Rheumatism, vol.35, issue.1, pp.31-38, 2005. ,
Comorbidity in arthritis, Journal of Rheumatology, vol.26, issue.11, pp.2475-2484, 1999. ,
Clinical comorbidity in patients with osteoarthritis: a case-control study of general practice consulters in England and Wales, Annals of the Rheumatic Diseases, vol.63, issue.4, pp.408-422, 2004. ,
A review of health-utility data for osteoarthritis: implications for clinical trial-based evaluation, Pharmacoeconomics, vol.26, issue.11, pp.925-960, 2008. ,
The value of utility: assumptions underlying preferences and quality adjusted life years, Journal of Rheumatology, vol.26, issue.9, pp.1861-1864, 1999. ,
The effect of co-morbidities on health-related quality of life in patients placed on the waiting list for total joint replacement. Health and Quality of Life Outcomes, vol.5, p.16, 2007. ,
A comparison of four different HRQoL generic questionnaires in five different patient groups, Rheumatology International, vol.30, issue.1, pp.63-70, 2009. ,
Is the health utilities index valid in total hip arthroplasty patients? Quality of Life Research, vol.13, pp.339-387, 2004. ,
Social support and health-related quality of life in hip and knee osteoarthritis, Quality of Life Research, vol.13, issue.2, pp.321-351, 2004. ,
Health-related quality of life in older adults with symptomatic hip and knee osteoarthritis: a comparison with matched healthy controls, Aging Clinical and Experimental Research, vol.17, issue.4, pp.255-63, 2005. ,
Comorbidity, limitations in activities and pain in patients with osteoarthritis of the hip or knee, BMC Musculoskeletal Disorders, vol.9, p.95, 2008. ,
The KHOALA cohort of knee and hip osteoarthritis in France, Joint Bone Spine, 2012. ,
URL : https://hal.archives-ouvertes.fr/hal-00932038
Prevalence of symptomatic hip and knee osteoarthritis: a two-phase population-based survey, Osteoarthritis Cartilage, vol.19, issue.11, pp.1314-1336, 2011. ,
Aggravating factors and therapeutic measures, Postgraduate Medical Journal, vol.80, issue.2, pp.150-63, 1986. ,
Criteria for classification of clinical osteoarthritis, Journal of Rheumatology. Supplement, vol.27, pp.10-12, 1991. ,
The development of a comorbidity index with physical function as the outcome, Journal of Clinical Epidemiology, vol.58, issue.6, pp.595-602, 2005. ,
Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee, Journal of Rheumatology, vol.15, issue.12, pp.1833-1873, 1988. ,
The impact of concomitant depression on quality of life and health service utilisation in patients with osteoarthritis, Rheumatology International, vol.27, issue.9, pp.859-63, 2007. ,
Pain and osteoarthritis in primary care: factors associated with pain perception in a sample of 1,021 patients, Pain Medicine, vol.9, issue.7, pp.903-913, 2008. ,
An approach to measuring and valuing health states, Social Science & Medicine -Medical Economics, vol.15, issue.2, pp.55-65, 1981. ,
Health-related quality of life in multiple musculoskeletal conditions: a crosssectional population based epidemiological study. II. The MAPPING study, Clinical and Experimental Rheumatology, vol.23, issue.6, pp.829-868, 2005. ,
Assessment of long-term physical function in acute respiratory distress syndrome (ARDS) patients: comparison of the Charlson comorbidity index and the functional comorbidity index, American Journal of Physical Medicine & Rehabilitation, vol.85, issue.7, pp.574-81, 2006. ,
A new method of classifying prognostic comorbidity in longitudinal studies: development and validation, Journal of Chronic Diseases, vol.40, issue.5, pp.373-83, 1987. ,
Validation of a measure of physical illness burden at autopsy: the cumulative illness rating scale, Journal of the American Geriatrics Society, vol.41, issue.1, pp.38-41, 1993. ,
The effect of medical comorbidity on self-reported shoulder-specific health related quality of life in patients with shoulder disease, Journal of Shoulder and Elbow Surgery, vol.19, issue.6, pp.823-831, 2010. ,
Low back pain and other musculoskeletal pain comorbidities in individuals with symptomatic osteoarthritis of the knee: data from the osteoarthritis initiative, Arthritis Care & Research, vol.62, pp.1715-1738, 2010. ,
Factors affecting self-reported pain and physical function in patients with hip osteoarthritis, Archives of Physical Medicine and Rehabilitation, vol.89, issue.6, pp.1066-73, 2008. ,
Clinical comorbidities, treatment patterns, and direct medical costs of patients with osteoarthritis in usual care: a retrospective claims database analysis, Journal of Medical Economics, vol.14, issue.4, pp.497-507, 2011. ,
Comorbidity of chronic diseases in general practice, Journal of Clinical Epidemiology, vol.46, issue.5, pp.469-73, 1993. ,
Longitudinal study of physical ability in the oldest-old, American Journal of Public Health, vol.79, issue.6, pp.698-702, 1989. ,
Advantages and limitations of utility assessment methods in rheumatoid arthritis, J Rheumatol, vol.34, pp.2193-200 ,
Guyatt GH Measurement of health status. Ascertaining the minimal clinically important difference, Control Clin Trials, vol.10, pp.407-422 ,
Methods to explain the clinical significance of health status measures, Mayo Clin Proc, vol.77, pp.371-83 ,
Walter SD Relation of distribution-and anchorbased approaches in interpretation of changes in health-related quality of life, Med Care, vol.39, pp.1039-1086 ,
Roughley PJ Cartilage in normal and osteoarthritis conditions, Best Pract Res Clin Rheumatol, vol.22, pp.351-84 ,
, Bitton R The economic burden of osteoarthritis, Am J Manag Care, vol.15, pp.230-235
Ang D Health care costs in US patients with and without a diagnosis of osteoarthritis, J Pain Res, vol.5, pp.23-30, 2012. ,
Comorbid conditions in the AMICA study patients: effects on the quality of life and drug prescriptions by general practitioners and specialists, Semin Arthritis Rheum, vol.35, pp.31-38 ,
Fallon WM Comorbidity in arthritis, J Rheumatol, vol.26, pp.2475-2484 ,
Croft PR Clinical comorbidity in patients with osteoarthritis: a case-control study of general practice consulters in England and Wales, Ann Rheum Dis, vol.63, pp.408-422 ,
Comorbid conditions in the AMICA study patients: effects on the quality of life and drug prescriptions by general practitioners and specialists, Semin Arthritis Rheum, vol.35, pp.31-38 ,
Clinical comorbidities, treatment patterns, and direct medical costs of patients with osteoarthritis in usual care: a retrospective claims database analysis, J Med Econ, vol.14, pp.497-507, 2011. ,
Comorbidity of chronic diseases in general practice, J Clin Epidemiol, vol.46, pp.469-73 ,
Longitudinal study of physical ability in the oldest-old, Am J Public Health, vol.79, pp.698-702 ,
Impact of co-morbidities on measuring indirect utility by the Medical Outcomes Study Short Form 6D in lower-limb osteoarthritis, Best Pract Res Clin Rheumatol, vol.26, pp.627-662 ,
URL : https://hal.archives-ouvertes.fr/hal-01557770
The KHOALA cohort of knee and hip osteoarthritis in France, Joint Bone Spine, vol.79, pp.597-603 ,
URL : https://hal.archives-ouvertes.fr/hal-00932038
Prevalence of symptomatic hip and knee osteoarthritis: a two-phase population-based survey, Osteoarthritis Cartilage, pp.1314-1336 ,
Aggravating factors and therapeutic measures, Postgrad Med, vol.80, pp.150-63 ,
, Altman RD Criteria for classification of clinical osteoarthritis, J Rheumatol Suppl, vol.27, pp.10-12
The development of a comorbidity index with physical function as the outcome, J Clin Epidemiol, vol.58, pp.595-602 ,
Stitt LW Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee, J Rheumatol, vol.15, pp.1833-1873 ,
The estimation of a preference-based measure of health from the SF-36, J Health Econ, vol.21, pp.271-92 ,
Sherbourne CD The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection, Med Care, vol.30, pp.473-83 ,
Wolinsky FD Further evidence supporting an SEM-based criterion for identifying meaningful intra-individual changes in health-related quality of life, J Clin Epidemiol, vol.52, pp.861-73 ,
Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes, J Clin Epidemiol, vol.61, pp.102-111 ,
Defining clinically meaningful change in health-related quality of life, J Clin Epidemiol, vol.56, pp.395-407 ,
Determining a minimal important change in a disease-specific Quality of Life Questionnaire, J Clin Epidemiol, vol.47, pp.81-88 ,
Huang IC SF-6D utility index as measure of minimally important difference in health status change, J Am Pharm Assoc, vol.52, pp.34-42, 2003. ,
A comparison of the measurement properties and estimation of minimal important differences of the EQ-5D and SF-6D utility measures in patients with systemic sclerosis, Clin Exp Rheumatol, vol.31, pp.50-56 ,
Validity, responsiveness, and minimal important difference for the SF-6D health utility scale in a spinal cord injured population, Value Health, vol.11 ,
Utility approach to measuring health-related quality of life, J Chronic Dis, vol.40, issue.6, pp.593-603, 1987. ,
An investigation into the empirical validity of the EQ-5D and SF-6D based on hypothetical preferences in a general population, Health Econ, vol.14, issue.11, pp.1169-89, 2005. ,
Advantages and limitations of utility assessment methods in rheumatoid arthritis, J Rheumatol, vol.34, issue.11, pp.2193-200, 2007. ,
Measurement of health status. Ascertaining the minimal clinically important difference, Control Clin Trials, vol.10, issue.4, pp.407-422, 1989. ,
Methods to explain the clinical significance of health status measures, Mayo Clin Proc, vol.77, issue.4, pp.371-83, 2002. ,
Relation of distribution-and anchorbased approaches in interpretation of changes in health-related quality of life, Med Care, vol.39, issue.10, pp.1039-1086, 2001. ,
Psychosocial health of living kidney donors: a systematic review, Am J Transplant, vol.6, issue.12, pp.2965-77, 2006. ,
Long-term follow-up of living kidney donors: quality of life after donation, Transplantation, vol.67, issue.5, pp.717-738, 1999. ,
Health-related quality of life of living kidney donors: review of the short form 36-health questionnaire survey, Transpl Int, vol.18, issue.12, pp.1309-1326, 2005. ,
Reduced quality of life in living kidney donors: association with fatigue, societal participation and pre-donation variables, Transpl Int, vol.25, issue.9, pp.967-75, 2012. ,
Assessment of healthrelated quality of life in living kidney donors, Transplant Proc, vol.43, issue.1, pp.373-378, 2011. ,
Living kidney donors--a prospective study of quality of life before and after kidney donation, Clin Transplant, vol.27, issue.1, pp.9-14, 2013. ,
The impact of living-related kidney transplantation on the donor's life, Transplantation, vol.81, issue.9, pp.1268-73, 2006. ,
Prospective psychosocial monitoring of living kidney donors using the Short Form-36 health survey: results at 12 months, Transplantation, vol.78, issue.9, pp.1384-1393, 2004. ,
The challenge of response shift for quality-of-life-based clinical oncology research, Ann Oncol, vol.10, issue.7, pp.747-756, 1999. ,
, EuroQol--a new facility for the measurement of health-related quality of life. The EuroQol Group, Health Policy, vol.16, issue.3, pp.199-208, 1990.
The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection, Med Care, vol.30, issue.6, pp.473-83, 1992. ,
Deriving a preference-based single index from the UK SF-36 Health Survey, J Clin Epidemiol, vol.51, issue.11, pp.1115-1143, 1998. ,
The estimation of a preference-based measure of health from the SF-36, J Health Econ, vol.21, issue.2, pp.271-92, 2002. ,
Valuing EQ-5D using time trade-off in France, Eur J Health Econ, vol.14, issue.1, pp.57-66, 2013. ,
Understanding the minimum clinically important difference: a review of concepts and methods, Spine J, vol.7, issue.5, pp.541-547, 2007. ,
Determining a minimal important change in a disease-specific Quality of Life Questionnaire, J Clin Epidemiol, vol.47, issue.1, pp.81-88, 1994. ,
Linking clinical relevance and statistical significance in evaluating intra-individual changes in health-related quality of life, Med Care, vol.37, issue.5, pp.469-78, 1999. ,
Revealing response shift in longitudinal research on fatigue--the use of the thentest approach, Acta Oncol, vol.38, issue.6, pp.709-727, 1999. ,
Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes, J Clin Epidemiol, vol.61, issue.2, pp.102-111, 2008. ,
Quality of life for donors after living donor liver transplantation: a review of the literature, Liver Transpl, vol.16, issue.12, pp.1352-1360, 2010. ,
Further evidence supporting an SEMbased criterion for identifying meaningful intra-individual changes in health-related quality of life, J Clin Epidemiol, vol.52, issue.9, pp.861-73, 1999. ,
Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6D, Qual Life Res, vol.14, issue.6, pp.1523-1555, 2005. ,
Valuing health states: a comparison of methods, J Health Econ, vol.15, issue.2, pp.209-240, 1996. ,
Theory of Games and Economic Behavior. sec ed, 1944. ,
The Foundations of Statistics, 1972. ,
, Critique des Postulats et Axiomes de l'Ecole Americaine, vol.21, pp.503-549, 1953.
, The Quarterly Journal of Economics, vol.75, issue.4, pp.643-69, 1961.
The construction of standard gamble utilities, Health Econ, vol.17, issue.1, pp.31-40, 2008. ,
Health values and prospect theory, Med Decis Making, vol.19, issue.3, pp.344-52, 1999. ,
Health related utility measurement: an introduction, J Rheumatol, vol.22, issue.6, pp.1197-1206, 1995. ,
A utility maximization model for evaluation of health care programs, Health Serv Res, vol.7, issue.2, pp.118-151, 1972. ,
Methods for the Economic Evaluation of Health Care Programmes, 2005. ,
Prospect Theory: An Analysis of Decision under Risk, Econometrica, vol.47, issue.2, pp.263-92, 1979. ,
The predictive validity of prospect theory versus expected utility in health utility measurement, J Health Econ, vol.28, issue.6, pp.1039-1086, 2009. ,
Toward a utility theory foundation for health status index models, Health Serv Res, vol.11, issue.4, pp.349-69, 1976. ,
Time preference, duration and health state valuations, Health Econ, vol.4, issue.4, pp.289-99, 1995. ,
Standard gamble, time trade-off and rating scale: experimental results on the ranking properties of QALYs, J Health Econ, 1997. ,
, Apr, vol.16, issue.2, pp.155-75
A new explanation for the difference between time trade-off utilities and standard gamble utilities, Health Econ, vol.11, issue.5, pp.447-56, 2002. ,
Variability among methods to assess patients' well-being and consequent effect on a cost-effectiveness analysis, J Clin Epidemiol, vol.45, issue.5, pp.505-517, 1992. ,
Associations between health status and utilities implications for policy, Med Care, vol.37, issue.5, pp.479-89, 1999. ,
The comparability and reliability of five health-state valuation methods, Soc Sci Med, vol.45, issue.11, pp.1641-52, 1997. ,
Preferences for health outcomes. Comparison of assessment methods, Med Decis Making, vol.4, issue.3, pp.315-344, 1984. ,
Quality of life in epilepsy: comparison of four preference measures, Epilepsy Res, vol.29, issue.3, pp.201-210, 1998. ,
Trends in the measurement of health utilities in published cost-utility analyses, Value Health, vol.9, issue.4, pp.213-221, 2006. ,
A review of the use of health status measures in economic evaluation, J Health Serv Res Policy, vol.4, issue.3, pp.174-84, 1999. ,
, EuroQol--a new facility for the measurement of health-related quality of life. The EuroQol Group, Health Policy, vol.16, issue.3, pp.199-208, 1990.
Deriving a preference-based single index from the UK SF-36 Health Survey, J Clin Epidemiol, vol.51, issue.11, pp.1115-1143, 1998. ,
Multi-attribute health status classification systems, Health Utilities Index. Pharmacoeconomics, 1995. ,
Valuing EQ-5D using time trade-off in France, Eur J Health Econ, vol.14, issue.1, pp.57-66, 2013. ,
The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection, Med Care, vol.30, issue.6, pp.473-83, 1992. ,
The estimation of a preference-based measure of health from the SF-36, J Health Econ, vol.21, issue.2, pp.271-92, 2002. ,
Validating and assessing the sensitivity of the Health Assessment Questionnaire-Disability Index-derived Short Form-6D in patients with early aggressive rheumatoid arthritis, J Rheumatol, vol.36, issue.6, pp.1150-1157, 2009. ,
Valuing health states: a comparison of methods, J Health Econ, vol.15, issue.2, pp.209-240, 1996. ,
Health-related quality of life--an introduction, Am J Manag Care, vol.13, issue.9, pp.218-223, 2007. ,
Interpreting the significance of changes in health-related quality-of-life scores, J Clin Oncol, vol.16, issue.1, pp.139-183, 1998. ,
Minimal change is sensitive, less specific to recovery: a diagnostic testing approach to interpretability, J Clin Epidemiol, vol.64, issue.5, pp.487-96, 2011. ,
Measurement of health status. Ascertaining the minimal clinically important difference, Control Clin Trials, vol.10, issue.4, pp.407-422, 1989. ,
Defining clinically meaningful change in health-related quality of life, J Clin Epidemiol, vol.56, issue.5, pp.395-407, 2003. ,
Minimal clinically important difference, low disease activity state, and patient acceptable symptom state: methodological issues, J Rheumatol, vol.32, issue.10, pp.2025-2034, 2005. ,
Feeling good rather than feeling better matters more to patients, Arthritis Rheum, vol.55, issue.4, pp.526-556, 2006. ,
Understanding the minimum clinically important difference: a review of concepts and methods ,
, Spine J, vol.7, issue.5, pp.541-547, 2007.
Methods to explain the clinical significance of health status measures, Mayo Clin Proc, vol.77, issue.4, pp.371-83, 2002. ,
Determining a minimal important change in a disease-specific Quality of Life Questionnaire, J Clin Epidemiol, 1994. ,
Hi! How are you? Response shift, implicit theories and differing epistemologies, Qual Life Res, vol.12, issue.3, pp.239-288, 2003. ,
Statistical Power Analysis for the Behavioral Sciences. L. Erlbaum Associates, 1988. ,
Further evidence supporting an SEMbased criterion for identifying meaningful intra-individual changes in health-related quality of life, J Clin Epidemiol, vol.52, issue.9, pp.861-73, 1999. ,
Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6D, Qual Life Res, 2005. ,
What is the relationship between the minimally important difference and health. Health Qual Life Outcomes, 2003. ,
The pre-therapeutic classification of co-morbidity in chronic disease, Journal of Chronic Diseases, vol.23, issue.7, pp.455-68, 1970. ,
Reduced quality of life in living kidney donors: association with fatigue, societal participation and pre-donation variables, Transpl Int, vol.25, issue.9, pp.967-75, 2012. ,
The treatment of unrelated disorders in patients with chronic medical diseases, N Engl J Med, vol.338, issue.21, pp.1516-1536, 1998. ,
Multimorbidity and quality of life in primary care: a systematic review, Health Qual Life Outcomes, vol.2, p.51, 2004. ,
Outcomes of total hip and knee replacement: preoperative functional status predicts outcomes at six months after surgery, Arthritis Rheum, vol.42, issue.8, pp.1722-1730, 1999. ,
Intramedullary versus extramedullary tibial cutting guide in severely obese patients undergoing total knee replacement: a randomized study of 70 patients with body mass index >35 kg/m2, Obes Surg, vol.18, issue.12, pp.1599-604, 2008. ,
,
, Multimorbidity -not just an older person's issue. Results from an Australian biomedical study, BMC Public Health, vol.10, p.718, 2010.
A new method of classifying prognostic comorbidity in longitudinal studies: development and validation, J Chronic Dis, vol.40, issue.5, pp.373-83, 1987. ,
Cumulative illness rating scale, J Am Geriatr Soc, vol.16, issue.5, pp.622-628, 1968. ,
The development of a comorbidity index with physical function as the outcome, J Clin Epidemiol, vol.58, issue.6, pp.595-602, 2005. ,
Comparative assessment of three different indices of multimorbidity for studies on health-related quality of life, Health Qual Life Outcomes, vol.3, p.74, 2005. ,
Underreporting by cancer patients: the case of responseshift, Soc Sci Med, vol.32, issue.9, pp.981-988, 1991. ,
The challenge of response shift for quality-of-lifebased clinical oncology research, Ann Oncol, vol.10, issue.7, pp.747-756, 1999. ,
Revealing response shift in longitudinal research on fatigue--the use of the thentest approach, Acta Oncol, vol.38, issue.6, pp.709-727, 1999. ,
Cartilage in normal and osteoarthritis conditions, Best Pract Res Clin Rheumatol, vol.22, issue.2, pp.351-84, 2008. ,
The economic burden of osteoarthritis, Am J Manag Care, vol.15, issue.8, pp.230-235, 2009. ,
Health care costs in US patients with and without a diagnosis of osteoarthritis, J Pain Res, vol.5, pp.23-30, 2012. ,
Comorbid conditions in the AMICA study patients: effects on the quality of life and drug prescriptions by general practitioners and specialists, Semin Arthritis Rheum, vol.35, issue.1, pp.31-38, 2005. ,
Comorbidity in arthritis, J Rheumatol, vol.26, issue.11, pp.2475-2484, 1999. ,
Clinical comorbidities, treatment patterns, and direct medical costs of patients with osteoarthritis in usual care: a retrospective claims database analysis, J Med Econ, vol.14, issue.4, pp.497-507, 2011. ,
Longitudinal study of physical ability in the oldest-old, Am J Public Health, vol.79, issue.6, pp.698-702, 1989. ,
Prevalence of symptomatic hip and knee osteoarthritis: a two-phase population-based survey, Osteoarthritis Cartilage, vol.19, issue.11, pp.1314-1336, 2011. ,
The KHOALA cohort of knee and hip osteoarthritis in France, Joint Bone Spine, 2012. ,
URL : https://hal.archives-ouvertes.fr/hal-00932038
Assessment of healthrelated quality of life in living kidney donors, Transplant Proc, vol.43, issue.1, pp.373-378, 2011. ,
Using instrument-defined health state transitions to estimate minimally important differences for four preference-based health-related quality of life instruments, Med Care, vol.48, issue.4, pp.365-71, 2010. ,
The concept of clinically meaningful difference in healthrelated quality-of-life research. How meaningful is it, Pharmacoeconomics, 2000. ,
Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes, J Clin Epidemiol, vol.61, issue.2, pp.102-111, 2008. ,
Global rating of change scales: a review of strengths and weaknesses and considerations for design, J Man Manip Ther, vol.17, issue.3, pp.163-70, 2009. ,
Standard Error of Measurement. Educational Measurement: Issues and Practice, vol.10, pp.33-41, 1991. ,
Identifying meaningful intra-individual change standards for health-related quality of life measures, J Eval Clin Pract, 2000. ,
Minimal important difference thresholds and the standard error of measurement: is there a connection?, J Biopharm Stat, vol.14, issue.1, pp.97-110, 2004. ,
Measuring health-related utility: why the disparity between EQ-5D and SF-6D?, Eur J Health Econ, vol.6, issue.3, pp.253-60, 2005. ,
A clarificatory note on 'Valuing health states: a comparison of methods, J Health Econ, vol.16, issue.5, p.617, 1997. ,
Valuing health-related quality of life. Issues and controversies, Pharmacoeconomics, vol.15, issue.2, pp.119-146, 1999. ,
The standard gamble showed better construct validity than the time trade-off, J Clin Epidemiol, 2007. ,
The impact of differences in EQ-5D and SF-6D utility scores on the acceptability of costutility ratios: results across five trial-based cost-utility studies, Value Health, 2010. ,
Not all "quality-adjusted life years" are equal, J Clin Epidemiol, vol.60, issue.6, pp.616-640, 2007. ,
Measuring preferences for cost-utility analysis: how choice of method may influence decision-making, Pharmacoeconomics, vol.25, issue.2, pp.93-106, 2007. ,
A comparison of the EQ-5D and SF-6D across seven patient groups, Health Econ, vol.13, issue.9, pp.873-84, 2004. ,
SF-6D versus EQ-5D: reasons for differences in utility scores and impact on, Eur J Health Econ, vol.10, issue.1, pp.15-23, 2009. ,
A comparative review of four preference-weighted measures of health-related quality of life, J Clin Epidemiol, vol.56, issue.4, pp.317-342, 2003. ,
An integrated method to determine meaningful changes in health-related quality of life, J Clin Epidemiol, 2004. ,
Measurement of health state utilities for economic appraisal, J Health Econ, vol.5, issue.1, pp.1-30, 1986. ,
Foundations of cost-effectiveness analysis for health and medical practices, N Engl J Med, vol.296, issue.13, pp.716-737, 1977. ,
QALYs: the basics, Value Health, vol.12, issue.1, pp.5-9, 2009. ,
, Annexe 2 : Questionnaire EQ-5D
, Veuillez indiquer, pour chacune des rubriques suivantes, l'affirmation qui décrit le mieux votre état de santé aujourd'hui, en cochant la case appropriée (X)
, %L'utilité%permet%de%valoriser%simultanément%le%résultat%clinique%et%son%impact%sur%l'état% de%santé%du%patient,%et%d'exprimer%ainsi%la%qualité%de%vie%liée%à%la%santé.%Nous%nous%sommes%intéressés%à% l'approche%indirecte%d'estimation%d'utilité%dérivée%à%partir%des%échelles%psychométriques%de%mesure%de% l'état%de%santé.%CelleDci%permet%de%répéter%la%mesure%dans%le%temps%et%ouvre%les%perspectives%d'analyses% à% l'évaluation%du%changement%d'utilité% au% cours%du%temps.% Les%objectifs% étaient% de%définir%un% seuil% de% changement%pour%l'utilité%dérivée%des%instruments%de%mesure%psychométrique%de%la%qualité%de%vie,%et% de%prendre%en%compte%dans%l'interprétation%du%seuil%la%présence%des%comorbidités%ou%d'un%phénomène% de% responseDshift.% Afin% de% répondre% à% nos% objectifs,% nous% avons% étudié,% d'une% part,% le% changement% d'utilité%mesurée%par%le%SFD6D%dans%une%cohorte%de%patients%atteints%d'arthrose%des%membres%inférieurs% (cohorte%KHOALA)%et%l'effet%des%comorbidités%sur%l'utilité%et%son%changement.%D'autre%part,%nous%avons% estimé%l'utilité%de%donneur%vivant%de%rein%à%partir%des%questionnaires%EQD5D%et%SFD6D%avant%et%3%mois% après%le%prélèvement%du%rein.%Un%seuil%de%changement%a%été%estimé%et%un%phénomène%de%responseDshift% a% été% recherché.% Les% résultats% ont% montré% l'effet% délétère% des% comorbidités% sur% la% mesure% d'utilité,% et% mis%en%évidence%l'importance%de%la%sévérité%fonctionnelle%de%l'arthrose%dans%l'expression%de%l'utilité%et% son%changement.%Chez%les%donneurs%vivants%nous%avons%mis%en%évidence%une%diminution%significative% de% l'utilité% à% court% terme,% avec% une% proportion% de% plus% de% 30%% de% donneurs% ayant%atteint% le% seuil% de% changement.% L'estimation% du% seuil% diffère% selon% la% population% étudiée,% l'instrument% de% mesure% de% l'utilité,%et%la%méthodologie%appliquée%pour%définir%ce%seuil.%En%conclusion,%l'évaluation%du%changement% d'utilité% doit% tenir% compte% de% l'existence% des% comorbidités% ainsi% que% de% l'adaptation% du% jugement% de% valeur%que%l'individu%porte%sur%son%état%de%santé%lorsque%celuiDci%évolue, Dans% le% domaine% de% la% santé,% la% mesure% d'utilité% permet% d'exprimer% la% valeur% que% peut% donner% un% individu% à% un% état% de% santé,% comprise% généralement% entre% 0% (la% mort)% et% 1% (meilleur% état% de% santé% envisageable)